BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 22919877)

  • 1. The efficacy of PPI after endoscopic hemostasis in patients with bleeding peptic ulcer and role of Helicobacter pylori.
    Gashi Z; Joksimovic N; Dragusha G; Bakalli A
    Med Arch; 2012; 66(4):236-9. PubMed ID: 22919877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised clinical trial: high-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers.
    Chen CC; Lee JY; Fang YJ; Hsu SJ; Han ML; Tseng PH; Liou JM; Hu FC; Lin TL; Wu MS; Wang HP; Lin JT
    Aliment Pharmacol Ther; 2012 Apr; 35(8):894-903. PubMed ID: 22369682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of high dose bolus versus continuous intravenous infusion pantoprazole as an adjunct therapy to therapeutic endoscopy in massive bleeding peptic ulcer.
    Yamada S; Wongwanakul P
    J Med Assoc Thai; 2012 Mar; 95(3):349-57. PubMed ID: 22550833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori infection does not affect the early rebleeding rate in patients with peptic ulcer bleeding after successful endoscopic hemostasis: a prospective single-center trial.
    Schilling D; Demel A; Nüsse T; Weidmann E; Riemann JF
    Endoscopy; 2003 May; 35(5):393-6. PubMed ID: 12701009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal dose of intravenous pantoprazole in patients with peptic ulcer bleeding requiring endoscopic hemostasis in Korea.
    Choi KD; Kim N; Jang IJ; Park YS; Cho JY; Kim JR; Shin JM; Jung HC; Song IS
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1617-24. PubMed ID: 19686407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous pantoprazole versus ranitidine for prevention of rebleeding after endoscopic hemostasis of bleeding peptic ulcers.
    Hsu PI; Lo GH; Lo CC; Lin CK; Chan HH; Wu CJ; Shie CB; Tsai PM; Wu DC; Wang WM; Lai KH
    World J Gastroenterol; 2004 Dec; 10(24):3666-9. PubMed ID: 15534928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: a U.S. multicenter randomized, double-blind study.
    Jensen DM; Pace SC; Soffer E; Comer GM;
    Am J Gastroenterol; 2006 Sep; 101(9):1991-9; quiz 2170. PubMed ID: 16968504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Guidelines of treatment for bleeding peptic ulcer disease].
    Chung IK; Lee DH; Kim HU; Sung IK; Kim JH; ;
    Korean J Gastroenterol; 2009 Nov; 54(5):298-308. PubMed ID: 19934611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose omeprazole infusion compared with scheduled second-look endoscopy for prevention of peptic ulcer rebleeding: a randomized controlled trial.
    Chiu PW; Joeng HK; Choi CL; Tsoi KK; Kwong KH; Lam SH; Sung JJ
    Endoscopy; 2016 Aug; 48(8):717-22. PubMed ID: 27275859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
    Gralnek IM; Dumonceau JM; Kuipers EJ; Lanas A; Sanders DS; Kurien M; Rotondano G; Hucl T; Dinis-Ribeiro M; Marmo R; Racz I; Arezzo A; Hoffmann RT; Lesur G; de Franchis R; Aabakken L; Veitch A; Radaelli F; Salgueiro P; Cardoso R; Maia L; Zullo A; Cipolletta L; Hassan C
    Endoscopy; 2015 Oct; 47(10):a1-46. PubMed ID: 26417980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapse prevention in reflux oesophagitis with regard to Helicobacter pylori status: a double-blind, randomized, multicentre trial to compare the efficacy of pantoprazole versus ranitidine.
    Adamek RJ; Behrendt J; Wenzel C
    Eur J Gastroenterol Hepatol; 2001 Jul; 13(7):811-7. PubMed ID: 11474311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial: intravenous pantoprazole vs. ranitidine for the prevention of peptic ulcer rebleeding: a multicentre, multinational, randomized trial.
    van Rensburg C; Barkun AN; Racz I; Fedorak R; Bornman PC; Beglinger C; Balanzó J; Devière J; Kupcinskas L; Luehmann R; Doerfler H; Schäfer-Preuss S
    Aliment Pharmacol Ther; 2009 Mar; 29(5):497-507. PubMed ID: 19053987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of intravenous pantoprazole with intravenous ranitidine in peptic ulcer bleeding.
    Demetrashvili ZM; Lashkhi IM; Ekaladze EN; Kamkamidze GK
    Georgian Med News; 2013 Oct; (223):7-11. PubMed ID: 24214585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: prospective randomized controlled trial.
    Zargar SA; Javid G; Khan BA; Yattoo GN; Shah AH; Gulzar GM; Sodhi JS; Mujeeb SA; Khan MA; Shah NA; Shafi HM
    J Gastroenterol Hepatol; 2006 Apr; 21(4):716-21. PubMed ID: 16677158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based clinical practice guidelines for peptic ulcer disease 2015.
    Satoh K; Yoshino J; Akamatsu T; Itoh T; Kato M; Kamada T; Takagi A; Chiba T; Nomura S; Mizokami Y; Murakami K; Sakamoto C; Hiraishi H; Ichinose M; Uemura N; Goto H; Joh T; Miwa H; Sugano K; Shimosegawa T
    J Gastroenterol; 2016 Mar; 51(3):177-94. PubMed ID: 26879862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitors after endoscopic hemostasis in patients with peptic ulcer bleeding.
    Mesihovic R; Vanis N; Mehmedovic A; Gornjakovic S; Gribajcevic M
    Med Arh; 2009; 63(6):323-7. PubMed ID: 20380111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of an intravenous proton pump inhibitor after endoscopic therapy with epinephrine injection for peptic ulcer bleeding in patients with uraemia: a case-control study.
    Tseng GY; Fang CT; Lin HJ; Yang HB; Tseng GC; Wang PC; Liao PC; Cheng YT; Huang CH
    Aliment Pharmacol Ther; 2009 Aug; 30(4):406-13. PubMed ID: 19485981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral or intravenous proton pump inhibitor in patients with peptic ulcer bleeding after successful endoscopic epinephrine injection.
    Tsai JJ; Hsu YC; Perng CL; Lin HJ
    Br J Clin Pharmacol; 2009 Mar; 67(3):326-32. PubMed ID: 19523014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose pantoprazole continuous infusion is superior to somatostatin after endoscopic hemostasis in patients with peptic ulcer bleeding.
    Tsibouris P; Zintzaras E; Lappas C; Moussia M; Tsianos G; Galeas T; Potamianos S
    Am J Gastroenterol; 2007 Jun; 102(6):1192-9. PubMed ID: 17378909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.